Announcements Trials
Browse Landscape

Phase

Phase 4 6Phase NA 5Phase 2 3Phase EARLY_PHASE1 1Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Tobacco Use Cessation 1Health Education 1

Interventions

Cyclophosphamide 142Gemcitabine 129Paclitaxel 125Radiotherapy 119Carboplatin 112Cisplatin 111pembrolizumab 110Nivolumab 106Docetaxel 90Rituximab 86Lenalidomide 77Dexamethasone 76Cytarabine 69Bevacizumab 64Fluorouracil 63Etoposide 63Oxaliplatin 62Filgrastim 59Peripheral Blood Stem Cell Transplantation 58Everolimus 58Capecitabine 58fludarabine phosphate 57Doxorubicin 56Temozolomide 55Prednisone 54Irinotecan 53Cetuximab 50fludarabine 48Ipilimumab 48Erlotinib Hydrochloride 48

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Completed × Tobacco Use Cessation Devices × Clear all
NCT02596711 2020-03-10

Project Impact 2: A Culturally Tailored Smoking Cessation Intervention for Latino Smokers

M.D. Anderson Cancer Center

Phase 1/2 Completed
26 enrolled 10 charts

Health Education, Tobacco Use Cessation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡